vincristine
Low (Specialist/Medical)Technical/Medical
Definition
Meaning
A chemotherapy medication used to treat various types of cancer, derived from the Madagascar periwinkle plant.
An alkaloid belonging to the vinca class of chemotherapeutic agents, functioning as a mitotic inhibitor by binding to tubulin and preventing microtubule formation, thereby arresting cell division in metaphase. It is particularly essential in treating acute lymphoblastic leukemia, Hodgkin lymphoma, and other malignancies.
Linguistics
Semantic Notes
The term is almost exclusively used in medical oncology. While 'vincristine' is the specific drug, 'vinca alkaloids' is the broader class term. It is often mentioned in the context of combination chemotherapy regimens, such as CHOP (Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone) where 'Oncovin' is the brand name for vincristine.
Dialectal Variation
British vs American Usage
Differences
No significant lexical differences. Dosage units and prescription conventions may follow regional medical standards.
Connotations
Identical clinical connotations of a potent, neurotoxic chemotherapy agent.
Frequency
Equally low frequency in both varieties, confined to medical contexts.
Vocabulary
Collocations
Grammar
Valency Patterns
The oncologist prescribed vincristine [for the patient's lymphoma].The regimen combines vincristine [with prednisone].Vocabulary
Synonyms
Neutral
Weak
Usage
Context Usage
Academic
Used in oncology research papers, clinical trial protocols, and pharmacology textbooks.
Everyday
Virtually never used in everyday conversation outside of a patient discussing their specific treatment.
Technical
Central to clinical notes, treatment plans, pharmacy orders, and discussions of neurotoxicity management.
Examples
By Part of Speech
adjective
British English
- The vincristine-induced neuropathy was carefully monitored.
- A standard vincristine-containing regimen was initiated.
American English
- The patient experienced vincristine-related side effects.
- The protocol calls for a vincristine-based combination.
Examples
By CEFR Level
- The doctor gave her medicine called vincristine.
- Vincristine is a strong drug for cancer.
- A common side effect of vincristine is nerve damage, which can cause tingling in the hands and feet.
- The treatment plan included several drugs, one of which was vincristine.
- Due to its dose-limiting neurotoxicity, vincristine administration requires meticulous monitoring of neurological function.
- The efficacy of the regimen relies heavily on the synergistic effect of vincristine with other alkylating agents.
Learning
Memory Aids
Mnemonic
Think: VINe + CRIStal + medicine. A crystalline medicine derived from a vine (the periwinkle plant).
Conceptual Metaphor
A MICROTUBULE DISRUPTER / MITOTIC STOP SIGN. It is conceptualized as an agent that physically halts the machinery of cell division.
Watch out
Common Pitfalls
Translation Traps (for Russian speakers)
- Do not confuse with 'Винкристин' (the direct transliteration) and other vinca alkaloids like 'vinblastine' ('Винбластин'). They are different drugs with different indications and toxicities.
Common Mistakes
- Misspelling as 'vincistine', 'vincristin'.
- Incorrect pronunciation placing stress on the first syllable (/ˈvɪn.krɪs.tin/).
- Using it as a general term for chemotherapy instead of the specific agent.
Practice
Quiz
What is the primary mechanism of action of vincristine?
FAQ
Frequently Asked Questions
No. Both are vinca alkaloids derived from the periwinkle plant, but they are distinct drugs with different chemical structures, clinical uses, and side effect profiles. Vincristine is more associated with neurotoxicity, while vinblastine more commonly causes bone marrow suppression.
It is poorly absorbed orally and can cause severe tissue damage and necrosis if it leaks outside the vein (extravasation). Intravenous administration ensures accurate dosing and direct delivery into the bloodstream.
Oncovin is a former brand name for vincristine sulfate. The name is still widely used in protocol acronyms (e.g., CHOP, where the 'O' stands for Oncovin).
No. It has specific activity against certain malignancies, most notably acute lymphoblastic leukaemia (ALL), Hodgkin and non-Hodgkin lymphomas, Wilms' tumour, and some sarcomas. Its use is determined by tumour type and treatment protocol.